Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

about

Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

Item

http://www.wikidata.org/entity/Q45064430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@en

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@nl

type

Item

label

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@en

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@nl

prefLabel

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@en

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@nl

P1476

Baseline Parameters in Clinica ...... ndations From the Liver Forum.

@en

P2093

Andrew J Muir

http://www.w3.org/2001/XMLSchema#string

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Brent A Neuschwander-Tetri

http://www.w3.org/2001/XMLSchema#string

Claudia Filozof

http://www.w3.org/2001/XMLSchema#string

David DeBrota

http://www.w3.org/2001/XMLSchema#string

Elmer Schabel

http://www.w3.org/2001/XMLSchema#string

Joanne C Imperial

http://www.w3.org/2001/XMLSchema#string

Lara Dimick-Santos

http://www.w3.org/2001/XMLSchema#string

Liver Forum’s Data Standardization Working Group

http://www.w3.org/2001/XMLSchema#string

Quentin M Anstee

http://www.w3.org/2001/XMLSchema#string

P2860

Drug-induced liver injury in obesity

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.

Role of cannabinoids in the development of fatty liver (steatosis)

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

P304

621-625.e7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1053/J.GASTRO.2017.07.024

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28757264

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5861348

http://www.w3.org/2001/XMLSchema#string